Bhargav Prasad

Title: Bhargav Prasad: Innovator in Biologics and CRISPR Technology

Introduction

Bhargav Prasad is a prominent inventor based in Chennai, India. He has made significant contributions to the field of biologics, particularly through his innovative work involving CRISPR technology. With a total of seven patents to his name, Prasad is recognized for his advancements in genetic engineering and therapeutic development.

Latest Patents

Prasad's latest patents include groundbreaking work on the DNA-binding domain of the CRISPR system. This patent focuses on a method of obtaining cells with modified fucosylation pathways, leading to the production of partially fucosylated and non-fucosylated protein products, specifically antibodies. The technology targets the Fut8 gene and GMD gene, which are crucial for developing therapeutics and biomarkers for disease diagnosis and prognosis. Another notable patent involves vectors for cloning and expressing genetic material, including antibody genes. This patent utilizes phage display technology to clone and screen potential antibody genes, facilitating the identification of lead molecules against various antigens.

Career Highlights

Bhargav Prasad is currently employed at Zumutor Biologics Inc., where he continues to push the boundaries of biotechnological research. His work has not only contributed to the scientific community but has also paved the way for advancements in medical therapeutics.

Collaborations

Prasad collaborates with talented individuals such as Divya Unnikrishnan and Kavitha Iyer Rodrigues, enhancing the innovative environment at Zumutor Biologics Inc. Their combined expertise fosters a culture of creativity and scientific exploration.

Conclusion

Bhargav Prasad stands out as a leading inventor in the field of biologics and CRISPR technology. His contributions are shaping the future of therapeutic development and genetic engineering.